<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04031626001917</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>HYLO NIGHT</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>55.2053</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-17T19:49:39.222Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311912219</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05397</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:22.529Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311912196</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>myVISC Visco 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05391</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:21.655Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911984</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05204</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:20.728Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911977</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 2.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05203</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:19.824Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911960</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05202</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:18.930Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911953</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05201</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:18.039Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911946</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 1.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05200</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:17.133Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911939</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Hanita Visco 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05198</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:16.248Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911878</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05159</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:14.437Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911861</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 2.2%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05158</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:13.533Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911854</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05157</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:12.626Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911847</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>Hypromel 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05148</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:11.731Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911748</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.8%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05089</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:09.027Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911731</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>EasyVisc 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05090</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:08.136Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911687</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>EasyLuron 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05056</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:01.096Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911670</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>EasyVisc 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04283</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:29:00.197Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911601</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>Pe-Ha-Visco Plus 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05009</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:59.283Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911595</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>Pe-Ha-Visco 2.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>05008</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:58.384Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911571</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 3.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>04998</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-06-17T11:28:57.479Z</lastUpdated>
  </row>
</eudamedExport>